Ipca Laboratories Ltd Annually Results

Gross Sales

7,705.04

6,244.32

5,829.79

5,419.99

4,648.71

Excise Duty

0

0

0

0

0

Net Sales

7,705.04

6,244.32

5,829.79

5,419.99

4,648.71

Other Operating Income

0

0

0

0

0

Other Income

124.77

125.62

66.57

62.84

67

Total Income

7,829.81

6,369.94

5,896.36

5,482.83

4,715.71

Total Expenditure

6,491.63

5,317.55

4,520.53

3,875.64

3,749.82

PBIDT

1,338.18

1,052.39

1,375.83

1,607.19

965.89

Interest

138.27

45.54

7.69

9.04

16.5

PBDT

1,199.91

1,006.85

1,368.14

1,598.15

949.39

Depreciation

357.24

261.56

232.42

209.17

210.5

Minority Interest Before NP

0

0

0

0

0

Tax

310.18

230.36

207.51

248.64

141.11

Deferred Tax

3.28

23

17.26

-8.5

-5.78

Reported Profit After Tax

529.21

491.93

910.95

1,148.84

603.56

Minority Interest After NP

-24.43

7.67

5.71

1.13

-2.76

Net Profit after Minority Interest

547.35

471.32

884.08

1,140.01

606.32

Extra-ordinary Items

-67.67

0

0

0

0

Adjusted Profit After Extra-ordinary item

615.02

471.32

884.08

1,140.01

606.32

EPS (Unit Curr.)

21.57

18.58

34.85

90.02

47.77

Book Value (Unit Curr.)

0

0

0

0

0

Dividend (%)

400

400

800

400

250

Equity

25.37

25.37

25.37

25.37

25.27

Public Shareholding (Number)

0

0

0

0

0

Public Shareholding (%)

0

0

0

0

0

Pledged/Encumbered - No. of Shares

0

0

0

0

0

Pledged/Encumbered - % in Total Promoters Holding

0

0

0

0

0

Pledged/Encumbered - % in Total Equity

0

0

0

0

0

Non Encumbered - No. of Shares

0

0

0

0

0

Non Encumbered - % in Total Promoters Holding

0

0

0

0

0

Non Encumbered - % in Total Equity

0

0

0

0

0

PBIDTM(%)

17.36

16.85

23.59

29.65

20.77

PBDTM(%)

15.57

16.12

23.46

29.48

20.42

PATM(%)

6.86

7.87

15.62

21.19

12.98